2m 2m 2m 2m 2m 2m 2m
Femasys (FEMY)
NASDAQ
$4.04-$0.04 (-0.98%)
Price as of Jun 23, 2026 7:10 PM EDT- $12.3MMarket Cap
- -77.36%1-Year Change
- Medical Instruments & SuppliesIndustry
Femasys (FEMY)
$4.04-$0.04 (-0.98%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.3M +40.77% | 1.6M +51.97% | 1.1M -11.13% | 1.2M +2.25% | |
Cost of Revenue | 872,400 +60.10% | 544,903 +43.37% | 380,069 -14.00% | 441,938 +19.32% | |
Gross Profit | 1.4M +31.06% | 1.1M +56.70% | 691,901 -9.47% | 764,280 -5.56% | |
Sales and Marketing Expense | 4.4M +10.26% | 4.0M +519.90% | 650,126 +16.33% | 558,852 +167.73% | |
Research and Development Expense | -7.6M -7.78% | -8.2M +13.98% | -7.2M +23.99% | -5.8M +42.34% | |
Depreciation and Amortization Expense | 46,175 +129.27% | 20,140 +511.41% | 3,294 -84.89% | 21,799 -45.47% | |
Total Operating Expenses | 19.0M +0.74% | 18.9M +24.14% | 15.2M +22.93% | 12.4M +35.19% | |
Operating Profit | -17.6M -1.11% | -17.8M +22.59% | -14.5M +25.07% | -11.6M +39.15% | |
Interest Income | 101,760 -82.53% | 582,354 N/A | 0 N/A | 0 -100.00% | |
Interest Expense | -504,069 -68.57% | -1.6M +869.57% | -165,390 +1,128.39% | -13,464 -29.97% | |
Interest Income and Expense and Net | -402,309 -60.61% | -1.0M +517.46% | -165,390 +1,128.39% | -13,464 -101.68% | |
Total Nonoperating Income and Expense | -1.0M +1.64% | -1.0M -484.45% | 265,629 +25.06% | 212,394 -73.55% | |
Income before Taxes | -18.6M -0.96% | -18.8M +32.05% | -14.2M +25.07% | -11.4M +51.16% | |
Income Taxes | 1,297 -86.49% | 9,602 +121.35% | 4,338 -31.14% | 6,300 +57.50% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -18.6M -1.00% | -18.8M +32.07% | -14.2M +25.04% | -11.4M +51.16% | |
Net Income from Continuing Operations Applicable to Common | -18.6M -1.00% | -18.8M +32.07% | -14.2M +25.04% | -11.4M +51.16% | |
Basic EPS and Net Income | -0.47 -44.71% | -0.85 -8.60% | -0.93 -3.12% | -0.96 -14.29% | |
Diluted EPS and Net Income | -0.47 -44.71% | -0.85 -8.60% | -0.93 -3.12% | -0.96 -14.29% | |
Basic Weighted Average Shares | 39.5M +77.61% | 22.3M +44.74% | 15.4M +30.21% | 11.8M +76.03% | |
Diluted Weighted Average Shares | 39.5M +77.61% | 22.3M +44.74% | 15.4M +30.21% | 11.8M +76.03% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 9.3M +168.45% | 3.5M -84.11% | 21.7M +67.54% | 13.0M -47.70% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 9.3M +168.45% | 3.5M -84.11% | 21.7M +67.54% | 13.0M -47.70% | |
Total Current Assets | 16.5M +105.13% | 8.0M -65.39% | 23.2M +64.02% | 14.1M -44.87% | |
Accumulated Depreciation | 3.8M +1.66% | 3.7M +5.51% | 3.5M +10.20% | 3.2M +18.19% | |
Property and Plant and Equipment and Net | 1.9M +18.76% | 1.6M +43.66% | 1.1M -25.08% | 1.5M -7.25% | |
Total Long-Term Assets | 940,232 -1.55% | 954,992 -12.11% | 1.1M +13.40% | 958,177 +46.19% | |
Total Assets | 20.7M +66.53% | 12.4M -55.16% | 27.8M +64.28% | 16.9M -40.88% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 0 -100.00% | 5.4M N/A | 0 -100.00% | 141,298 -21.99% | |
Total Current Liabilities | 3.6M -57.63% | 8.6M +181.03% | 3.1M +99.90% | 1.5M -9.71% | |
Total Long-Term Debt | 3.2M N/A | 0 -100.00% | 4.3M N/A | 0 N/A | |
Total Long-Term Liabilities | 11.2M +620.20% | 1.6M -75.47% | 6.3M +4,969.53% | 125,242 -77.32% | |
Total Liabilities | 14.9M +46.49% | 10.1M +7.84% | 9.4M +468.84% | 1.7M -26.34% | |
Retained Earnings | -145.8M +14.64% | -127.2M +17.36% | -108.4M +15.13% | -94.1M +13.77% | |
Total Stockholders Equity | 5.9M +154.70% | 2.3M -87.44% | 18.4M +20.40% | 15.2M -42.11% | |
Total Shares Outstanding | 59.6M +155.19% | 23.4M +7.84% | 21.7M +82.46% | 11.9M +0.56% | |
Cash Flow | |||||
Cash from Operating Activities | -18.7M -3.87% | -19.4M +72.37% | -11.3M +5.11% | -10.7M +35.32% | |
Capital Expenditures | 525,007 -31.07% | 761,706 +429.27% | 143,917 -64.68% | 407,475 +32.79% | |
Cash from Investing Activities | -630,098 -25.68% | -847,764 +489.06% | -143,917 -64.68% | -407,475 +32.79% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 25.1M +1,139.74% | 2.0M -89.95% | 20.2M +3,060.28% | -681,645 -102.30% | |
Financials Ratio | |||||
Gross Margin | 61.96% -6.90% | 66.55% +3.11% | 64.54% +1.87% | 63.36% N/A | |
Operating Margin | -766.95% -29.75% | -1,091.75% -19.33% | -1,353.43% +40.73% | -961.71% N/A | |
Return on Assets | -112.32% +19.98% | -93.61% +46.69% | -63.81% +27.34% | -50.11% N/A | |
Return on Equity | -455.80% +150.19% | -182.18% +114.79% | -84.82% +54.74% | -54.81% N/A | |
Revenue Growth | 40.77% -21.55% | 51.97% +566.98% | -11.13% -594.92% | 2.25% N/A | |
Current Ratio | 4.53 +384.19% | 0.93 -87.68% | 7.59 -17.95% | 9.25 N/A | |
Cash Ratio | 2.55 +533.62% | 0.40 -94.34% | 7.11 -16.19% | 8.48 N/A | |
Debt-to-Equity Ratio | 0.54 -76.91% | 2.35 +911.21% | 0.23 +2,394.62% | 0.009 N/A | |
Debt-to-Assets Ratio | 0.15 -64.69% | 0.43 +183.18% | 0.15 +1,726.19% | 0.008 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow